Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC

被引：0
|
作者：
Wilhelm Graf
Peter H. Cashin
Lana Ghanipour
Malin Enblad
Johan Botling
Alexei Terman
Helgi Birgisson
机构：
[1] Uppsala University,Department of Surgical Sciences, Akademiska sjukhuset
[2] Uppsala University,Department of Immunology, Genetics and Pathology, Clinical and Experimental Pathology, Akademiska sjukhuset
来源：
Annals of Surgical Oncology | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：293 / 300
页数：7
相关论文
共 50 条
  • [1] Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC
    Graf, Wilhelm
    Cashin, Peter H.
    Ghanipour, Lana
    Enblad, Malin
    Botling, Johan
    Terman, Alexei
    Birgisson, Helgi
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (01) : 293 - 300
  • [2] Impact of KRAS/BRAF Mutations in Patients with Colorectal Peritoneal Metastases
    Wright, G.
    Zureikat, A.
    Pingpank, J. F.
    Holtzman, M.
    Ahrendt, S.
    Ramalingam, L.
    Zeh, H., III
    Bartlett, D.
    Choudry, M. A.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S93 - S93
  • [3] Incidence and Prognostic Impact of KRAS and BRAF Mutation in Patients Undergoing Liver Surgery for Colorectal Metastases
    Karagkounis, Georgios
    Torbenson, Michael S.
    Daniel, Hubert D.
    Azad, Nilofer S.
    Diaz, Luis A., Jr.
    Donehower, Ross C.
    Hirose, Kenzo
    Ahuja, Nita
    Pawlik, Timothy M.
    Choti, Michael A.
    CANCER, 2013, 119 (23) : 4137 - 4144
  • [4] Prognostic factors for early recurrences following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases
    Chandran, N.
    Tan, G.
    Chia, C.
    Teo, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [5] Prognostic Value of KRAS Gene Mutation on Survival of Patients with Peritoneal Metastases of Colorectal Adenocarcinoma
    Diez-Alonso, Manuel
    Mendoza-Moreno, Fernando
    Gomez-Sanz, Remedios
    Matias-Garcia, Belen
    Ovejero-Merino, Enrique
    Molina, Raquel
    Soto-Schutte, Sonia
    San Juan, Alberto
    Gutierrez-Calvo, Alberto
    INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY, 2021, 2021
  • [6] CRS and HIPEC for patients with peritoneal metastases of gastric cancer
    Brandl, A.
    Raue, W.
    Reich, J.
    Pratschke, J.
    Raue, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 83 - 83
  • [7] Impact of BRAF and KRAS mutation on oncological outcomes in patients with colorectal peritoneal metastases undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Flood, Michael
    Waters, Peadar
    Ramsay, Robert
    Michael, Michael
    Tie, Jeanne
    Heriot, Alexander
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 121 - 122
  • [8] Defining 'High' Peritoneal Cancer Index as a Prognostic Factor in Appendiceal Cancer Patients Treated with CRS/HIPEC
    Lopez-Ramirez, Felipe
    Sardi, Armando
    King, Mary Caitlin
    Nikiforchin, Andrei
    Baron, Ekaterina
    Nieroda, Carol
    Gushchin, Vadim
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 468 - 469
  • [9] Incidence and prognostic impact of KRAS and BRAF mutations in patients undergoing liver surgery for colorectal metastases
    Karagkounis, Georgios
    Torbenson, Michael S.
    Daniel, Hubert D.
    Azad, Nilofer Saba
    Diaz, Luis A.
    Donehower, Ross C.
    Hirose, Kenzo
    Pawlik, Timothy M.
    Choti, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] In Patients Undergoing CRS/HIPEC for Colorectal Adenocarcinoma with Peritoneal Metastases, Presence of Ascites on Computed Tomography Imaging is not a Prognostic Marker for Survival
    Ibrahim Said
    Inge Ubink
    Roos S. G. Ewalds
    Johanna G. T. Arkesteijn
    Henk M. W. Verheul
    Johannes H. W. de Wilt
    Helena M. Dekker
    Andreas J. A. Bremers
    Philip R. de Reuver
    Annals of Surgical Oncology, 2022, 29 : 5256 - 5262
12345